MedPath
FDA Approval

TRULICITY

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Dulaglutide(3.0 mg in 0.5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TRULICITY

Product Details

NDC Product Code
50090-6571
Application Number
BLA125469
Marketing Category
BLA (C73585)
Route of Administration
SUBCUTANEOUS
Effective Date
January 19, 2021
Anhydrous Citric AcidInactive
Code: XF417D3PSLClass: IACTQuantity: 0.07 mg in 0.5 mL
MannitolInactive
Code: 3OWL53L36AClass: IACTQuantity: 23.2 mg in 0.5 mL
Code: WTT295HSY5Class: ACTIBQuantity: 3.0 mg in 0.5 mL
Trisodium Citrate DihydrateInactive
Code: B22547B95KClass: IACTQuantity: 1.37 mg in 0.5 mL
Polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.125 mg in 0.5 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath